Loading...
Loading...
NVTA| Name | Value |
|---|---|
| Revenues | 121.2M |
| Cost of Revenue | 82.2M |
| Gross Profit | 39.1M |
| Operating Expense | 142.0M |
| Operating I/L | -980.2M |
| Other Income/Expense | -838.7M |
| Interest Income | 4.5M |
| Pretax | -948.3M |
| Income Tax Expense | -6.2M |
| Net Income/Loss | -942.1M |
Invitae Corporation is a medical genetics company that provides genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and rare diseases. Additionally, the company offers digital health solutions and health data services. It serves patients, healthcare providers, biopharma companies, and other partners, integrating genetic information into mainstream medicine to improve healthcare. The company generates revenue through the sale of genetic tests, digital health solutions, and health data services, catering to the needs of individuals and organizations in the United States, Canada, and internationally.
